Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression

HPB

Volumn 15, Issue 9, 2013, Pages 661-667

  Dudeja, Vikas ^a   Greeno, Edward W ^b   Walker, Sidney P ^b   Jensen, Eric H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEPATIC ARTERY; HUMAN; MALE; PANCREAS ADENOCARCINOMA; PORTAL VEIN; SUPERIOR MESENTERIC ARTERY; SUPERIOR MESENTERIC VEIN; TREATMENT RESPONSE; TUMOR REGRESSION;

ADENOCARCINOMA; AGED; CHEMORADIOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84882451663     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12015     Document Type: Article

References (19)

1. Jemal A, Siegel R, Xu J, Ward E,. (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Warshaw AL, Gu ZY, Wittenberg J, Waltman AC,. (1990) Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 125: 230-233.
3. Kim HJ, Czischke K, Brennan MF, Conlon KC,. (2002) Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 6: 763-769.
4. Mehta VK, Fisher G, Ford JA, Poen JC, Vierra MA, Oberhelman H, et al. (2001) Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg 5: 27-35.
5. Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, et al. (2000) Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 135: 81-87; discussion 8.
6. White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, et al. (1999) Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 6: 38-45.
7. Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC,. (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16: 1727-1733.
8. Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, et al. (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206: 833-846; discussion 46-8.
9. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, et al. (2008) Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26: 3487-3495.
10. Abrams RA, Lowy AM, O'Reilly EM, Wolff RA, Picozzi VJ, Pisters PW,. (2009) Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16: 1751-1756.
11. Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, et al. (2011) Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. Ann Surg Oncol 18: 3615-3622.
12. Picozzi VJ, Kozarek RA, Traverso LW,. (2003) Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 185: 476-480.
13. Habermehl D, Kessel K, Welzel T, Hof H, Abdollahi A, Bergmann F, et al. (2012) Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol 7: 28.
14. Arvold ND, Ryan DP, Niemierko A, Blaszkowsky LS, Kwak EL, Wo JY, et al. (2012) Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer. Cancer 118: 3026-3035.
15. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216.
16. Evans DB, Erickson BA, Ritch P,. (2010) Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. Ann Surg Oncol 17: 2803-2805.
17. Patel M, Hoffe S, Malafa M, Hodul P, Klapman J, Centeno B, et al. (2011) Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. J Surg Oncol 104: 155-161.
18. Nukui Y, Picozzi VJ, Traverso LW,. (2000) Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 179: 367-371.
19. Picozzi VJ, Abrams RA, Decker PA, Traverso W, O'Reilly EM, Greeno E, et al. (2011) Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol 22: 348-354.